Mohamed A. Alfaleh

1.8k total citations
41 papers, 1.0k citations indexed

About

Mohamed A. Alfaleh is a scholar working on Infectious Diseases, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mohamed A. Alfaleh has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mohamed A. Alfaleh's work include SARS-CoV-2 and COVID-19 Research (12 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and COVID-19 Clinical Research Studies (5 papers). Mohamed A. Alfaleh is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and COVID-19 Clinical Research Studies (5 papers). Mohamed A. Alfaleh collaborates with scholars based in Saudi Arabia, Egypt and United States. Mohamed A. Alfaleh's co-authors include Anwar M. Hashem, Nabil A. Alhakamy, Martina L. Jones, Stephen M. Mahler, Ahmad Bakur Mahmoud, Almohanad A. Alkayyal, Abdullah Algaissi, Hashem O. Alsaab, Hibah M. Aldawsari and Shadab Md and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Mohamed A. Alfaleh

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohamed A. Alfaleh Saudi Arabia	17	424	223	206	111	108	41	1.0k
Philipp Uhl Germany	17	424 1.0×	76 0.3×	85 0.4×	150 1.4×	78 0.7×	58	876
Shantanu Ganguly India	16	336 0.8×	108 0.5×	306 1.5×	87 0.8×	119 1.1×	33	994
Mikiro Nakashima Japan	21	583 1.4×	130 0.6×	158 0.8×	255 2.3×	99 0.9×	120	1.5k
Jalal Abdolalizadeh Iran	23	720 1.7×	167 0.7×	72 0.3×	29 0.3×	119 1.1×	75	1.4k
Annekathrin Haberland Germany	22	691 1.6×	108 0.5×	64 0.3×	340 3.1×	66 0.6×	70	1.5k
Manouchehr Teymouri Iran	18	440 1.0×	49 0.2×	97 0.5×	56 0.5×	210 1.9×	30	1.1k
Vikas Jain India	20	571 1.3×	59 0.3×	145 0.7×	85 0.8×	45 0.4×	61	1.2k
Praveen Kumar Gaur India	20	434 1.0×	89 0.4×	43 0.2×	431 3.9×	60 0.6×	103	1.3k
Shijie Xu China	19	487 1.1×	75 0.3×	155 0.8×	14 0.1×	116 1.1×	43	1.0k
Jin Hu China	22	489 1.2×	86 0.4×	78 0.4×	17 0.2×	242 2.2×	42	1.4k

Countries citing papers authored by Mohamed A. Alfaleh

Since Specialization

Citations

This map shows the geographic impact of Mohamed A. Alfaleh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed A. Alfaleh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed A. Alfaleh more than expected).

Fields of papers citing papers by Mohamed A. Alfaleh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed A. Alfaleh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed A. Alfaleh. The network helps show where Mohamed A. Alfaleh may publish in the future.

Co-authorship network of co-authors of Mohamed A. Alfaleh

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed A. Alfaleh. A scholar is included among the top collaborators of Mohamed A. Alfaleh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed A. Alfaleh. Mohamed A. Alfaleh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alfaleh, Mohamed A., Mohammed Razeeth Shait Mohammed, Anwar M. Hashem, et al.. (2023). Extracellular matrix detached cancer cells resist oxidative stress by increasing histone demethylase KDM6 activity. Saudi Journal of Biological Sciences. 31(1). 103871–103871. 6 indexed citations

Alhabbab, Rowa Y., Abdullah Algaissi, Ahmad Bakur Mahmoud, et al.. (2022). Middle East Respiratory Syndrome Coronavirus Infection Elicits Long-lasting Specific Antibody, T and B Cell Immune Responses in Recovered Individuals. Clinical Infectious Diseases. 76(3). e308–e318. 9 indexed citations

Alhakamy, Nabil A., Shaimaa M. Badr-Eldin, Osama A. A. Ahmed, et al.. (2022). Green Nanoemulsion Stabilized by In Situ Self-Assembled Natural Oil/Native Cyclodextrin Complexes: An Eco-Friendly Approach for Enhancing Anticancer Activity of Costunolide against Lung Cancer Cells. Pharmaceutics. 14(2). 227–227. 11 indexed citations

Al-Rabia, Mohammed W., Mohamed A. Alfaleh, Hani Z. Asfour, et al.. (2022). 2-Methoxyestradiol TPGS Micelles Attenuate Cyclosporine A-Induced Nephrotoxicity in Rats through Inhibition of TGF-β1 and p-ERK1/2 Axis. Antioxidants. 11(8). 1499–1499. 4 indexed citations

Alharbi, Waleed S., Mohamed A. Alfaleh, Nabil A. Alhakamy, et al.. (2022). Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment. Pharmaceutics. 14(12). 2627–2627. 23 indexed citations

Yahya, Galal, et al.. (2022). Combination of Meropenem and Zinc Oxide Nanoparticles; Antimicrobial Synergism, Exaggerated Antibiofilm Activity, and Efficient Therapeutic Strategy against Bacterial Keratitis. Antibiotics. 11(10). 1374–1374. 33 indexed citations

Ullah, Aman, Anastasiia D. Shkodina, Dmytro I. Boiko, et al.. (2022). Drug reprofiling history and potential therapies against Parkinson’s disease. Frontiers in Pharmacology. 13. 1028356–1028356. 12 indexed citations

Alfaleh, Mohamed A., Anwar M. Hashem, Turki S. Abujamel, et al.. (2022). Apigenin Loaded Lipoid–PLGA–TPGS Nanoparticles for Colon Cancer Therapy: Characterization, Sustained Release, Cytotoxicity, and Apoptosis Pathways. Polymers. 14(17). 3577–3577. 22 indexed citations

Alghamdi, Abdullah, Rahaf Alharbi, Ahmed M. Hassan, et al.. (2022). Mouth rinses efficacy on salivary SARS‐CoV‐2 viral load: A randomized clinical trial. Journal of Medical Virology. 95(1). e28412–e28412. 14 indexed citations

10.

Alharbi, Rahaf, Rowa Y. Alhabbab, Sawsan S. Alamri, et al.. (2021). Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1. Vaccines. 9(8). 852–852. 12 indexed citations

11.

Singh, Tanveer, Mohammed M. Ghoneim, Sultan Alshehri, et al.. (2021). Recent Developments in Diagnosis of Epilepsy: Scope of MicroRNA and Technological Advancements. Biology. 10(11). 1097–1097. 25 indexed citations

12.

Alhakamy, Nabil A., Usama A. Fahmy, Shaimaa M. Badr-Eldin, et al.. (2021). Scorpion Venom-Functionalized Quercetin Phytosomes for Breast Cancer Management: In Vitro Response Surface Optimization and Anticancer Activity against MCF-7 Cells. Polymers. 14(1). 93–93. 35 indexed citations

13.

Alhabbab, Rowa Y., Ahdab Alsaieedi, Abdullah Algaissi, et al.. (2021). Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia. Viruses. 13(7). 1413–1413. 13 indexed citations

14.

Akhter, Md Habban, Habibullah Khalilullah, Manish Gupta, et al.. (2021). Impact of Protein Corona on the Biological Identity of Nanomedicine: Understanding the Fate of Nanomaterials in the Biological Milieu. Biomedicines. 9(10). 1496–1496. 56 indexed citations

15.

Md, Shadab, Nabil A. Alhakamy, Hibah M. Aldawsari, et al.. (2021). Plumbagin-Loaded Glycerosome Gel as Topical Delivery System for Skin Cancer Therapy. Polymers. 13(6). 923–923. 45 indexed citations

16.

Alhakamy, Nabil A., Ahmed L. Alaofi, Osama A. A. Ahmed, et al.. (2020). Development of lipid membrane based assays to accurately predict the transfection efficiency of cell-penetrating peptide-based gene nanoparticles. International Journal of Pharmaceutics. 580. 119221–119221. 7 indexed citations

17.

Hashem, Anwar M., Rowa Y. Alhabbab, Abdullah Algaissi, et al.. (2020). Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies. Pathogens. 9(12). 1067–1067. 7 indexed citations

18.

Alfaleh, Mohamed A., Hashem O. Alsaab, Ahmad Bakur Mahmoud, et al.. (2020). Phage Display Derived Monoclonal Antibodies: From Bench to Bedside. Frontiers in Immunology. 11. 1986–1986. 179 indexed citations

19.

Alhakamy, Nabil A., Usama A. Fahmy, Osama A. A. Ahmed, et al.. (2019). Development of an optimized febuxostat self-nanoemulsified loaded transdermal film: in-vitro, ex-vivo and in-vivo evaluation. Pharmaceutical Development and Technology. 25(3). 326–331. 15 indexed citations

20.

Jones, Martina L., Mohamed A. Alfaleh, Shuo Zhang, et al.. (2016). Targeting membrane proteins for antibody discovery using phage display. Scientific Reports. 6(1). 26240–26240. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact